Literature DB >> 17616311

Evidence-based respiratory medicine in horses.

Katherine K Williamson1, Michael S Davis.   

Abstract

It is clear from a review of the current scientific literature that an evidence-based approach to medical treatment of equine respiratory disease can be applied, at least in the instance of common lower respiratory diseases. In particular, there is clear evidence for efficacious treatments for recurrent airway obstruction and exercise-induced pulmonary hemorrhage, and with the recognition of this evidence, these treatments should be the first to be considered by a practitioner when treating these conditions. The purpose of this article is not only to identify the existence of relevant high-quality studies for incorporation into an evidence-based veterinary medicine approach to patient care, but to highlight the features of those studies that should be considered when evaluating their value in individual situations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616311     DOI: 10.1016/j.cveq.2007.03.006

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  4 in total

Review 1.  Anesthesia of the geriatric equine.

Authors:  Reza Seddighi; Thomas J Doherty
Journal:  Vet Med (Auckl)       Date:  2012-08-03

2.  Oxidant-antioxidant status in the blood of horses with symptomatic recurrent airway obstruction (RAO).

Authors:  A Niedzwiedz; Z Jaworski
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

3.  Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect.

Authors:  John Klier; Carolin Bartl; Sabine Geuder; Katharina J Geh; Sven Reese; Lutz S Goehring; Gerhard Winter; Heidrun Gehlen
Journal:  Immun Inflamm Dis       Date:  2019-05-29

4.  Neutrophil and macrophage apoptosis in bronchoalveolar lavage fluid from healthy horses and horses with recurrent airway obstruction (RAO).

Authors:  Artur Niedzwiedz; Zbigniew Jaworski; Bartlomiej Tykalowski; Marcin Smialek
Journal:  BMC Vet Res       Date:  2014-01-24       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.